AKR-302

N/A

Report date: 2023/02/25 20:21:30
NME

Base Information

Drug NameAKR-302
Drug Alias NameAKR-302
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLymphoma, Large-Cell, Anaplastic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAkron Molecules Ag
China Registration ClassN/A

Develop Information

Active CompaniesAkron Molecules Ag
Inactive CompaniesN/A
Active IndicationsLymphoma, Large-Cell, Anaplastic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A